Literature DB >> 19762396

Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort.

A M Bertoli1, L M Vilá, G S Alarcón, G McGwin, J C Edberg, M Petri, R Ramsey-Goldman, J D Reveille, R P Kimberly.   

Abstract

The objective of this study was to determine the factors associated with the occurrence of arterial vascular events in a multiethnic systemic lupus erythematosus (SLE) cohort. The PROFILE cohort, comprised SLE patients (n = 1333) of defined ethnicity from five different US institutions, was studied to determine demographic, clinical and biological variables associated with vascular events. An arterial vascular event (first episode) was either a myocardial infarction, angina pectoris and/or a vascular procedure for myocardial infarction, stroke, claudication and/or evidence of gangrene. Patient characteristics were analyzed by univariable and multivariable Cox proportional hazards regression analyses. One-hundred twenty-three (9.8%) patients had at least one incident arterial event. Age at cohort enrollment (HR = 1.04, 95% CI 1.03-1.06), smoking (HR = 2.20, 95% CI 1.40-3.46) and the CRP2* C alleles (HR = 1.91, 95% CI 1.04-3.49) were associated with a shorter time-to-the occurrence of arterial vascular events. Some clinical manifestations of disease activity were associated with a shorter time-to-occurrence [psychosis (HR = 2.21, 95% CI 1.10-4.44), seizures (HR = 1.85, 95% CI 1.00-3.24) and anaemia (HR = 1.83, 95% CI 1.02-3.31)], but others were not [arthritis (HR = 0.32, 95% CI 0.18-0.58)]. In conclusion, older patients, especially in the context of a predisposing environmental factor (smoking) and severe clinical manifestations, are at higher risk of having arterial vascular events. The genetic contribution of the variation at the CRP locus was not obscured by demographic or clinical variables. Awareness of these factors should lead to more effective management strategies of patients at risk for arterial vascular events.

Entities:  

Mesh:

Year:  2009        PMID: 19762396      PMCID: PMC2846757          DOI: 10.1177/0961203309104862

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  58 in total

1.  Relation between markers of systemic vascular inflammation and smoking in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie E Buring; JoAnn E Manson; Paul M Ridker
Journal:  Am J Cardiol       Date:  2002-05-01       Impact factor: 2.778

2.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

3.  The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; P Fortin; E Ginzler; C Gordon; J G Hanly; D A Isenberg; M Petri; O Nived; M Snaith; G Sturfelt
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

4.  Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Authors:  F J Muñoz-Rodríguez; J C Reverter; J Font; D Tàssies; R Cervera; G Espinosa; F Carmona; J Balasch; A Ordinas; M Ingelmo
Journal:  Haematologica       Date:  2000-06       Impact factor: 9.941

5.  Baseline characteristics of a multiethnic lupus cohort: PROFILE.

Authors:  G S Alarcón; G McGwin; M Petri; J D Reveille; R Ramsey-Goldman; R P Kimberly
Journal:  Lupus       Date:  2002       Impact factor: 2.911

6.  Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.

Authors:  Robert Y L Zee; Paul M Ridker
Journal:  Atherosclerosis       Date:  2002-05       Impact factor: 5.162

7.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

Authors:  Leslie A Lange; Christopher S Carlson; Lucia A Hindorff; Ethan M Lange; Jeremy Walston; J Peter Durda; Mary Cushman; Joshua C Bis; Donglin Zeng; Danyu Lin; Lewis H Kuller; Deborah A Nickerson; Bruce M Psaty; Russell P Tracy; Alexander P Reiner
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

8.  Cigarette smoking and disease activity in systemic lupus erythematosus.

Authors:  Najeeb O Ghaussy; Wilmer Sibbitt; Arthur D Bankhurst; Clifford R Qualls
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

10.  Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.

Authors:  Andrew I Russell; Deborah S Cunninghame Graham; Christopher Shepherd; Cheri A Roberton; John Whittaker; John Meeks; Richard J Powell; David A Isenberg; Mark J Walport; Timothy J Vyse
Journal:  Hum Mol Genet       Date:  2003-11-25       Impact factor: 6.150

View more
  16 in total

1.  Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus.

Authors:  D K Wells; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2010-05-13       Impact factor: 4.473

2.  Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.

Authors:  Laurence S Magder; Michelle Petri
Journal:  Am J Epidemiol       Date:  2012-09-27       Impact factor: 4.897

Review 3.  Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians.

Authors:  Kai-Hang Yiu; Hung-Fat Tse; Mo-Yin Mok; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

4.  Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus.

Authors:  Xiao-Yang Wang; Xue-Qing Tang; Ya-Juan Huang; Wei-Ying Chen; Xue-Qing Yu
Journal:  Clin Rheumatol       Date:  2011-12-23       Impact factor: 2.980

5.  Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.

Authors:  Nicholas A Young; Kyle Jablonski; Emmy Schwarz; Ifeoma Okafor; Jeffrey Hampton; Giancarlo R Valiente; Caitlin Henry; Peter Harb; Jessica Barger; Anna Bratasz; Anuradha Kalyanasundaram; Stacy P Ardoin; Wael N Jarjour
Journal:  Lupus       Date:  2020-10-12       Impact factor: 2.911

6.  Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases.

Authors:  Nahoko Tanaka; Shotaro Masuoka; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  Metabolites       Date:  2016-09-16

Review 7.  Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Authors:  Vítor Teixeira; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2018-01-29

8.  Asymptomatic Carotid Atherosclerosis Cardiovascular Risk Factors and Common Hypertriglyceridemia Genetic Variants in Patients with Systemic Erythematosus Lupus.

Authors:  Marta Fanlo-Maresma; Beatriz Candás-Estébanez; Virginia Esteve-Luque; Ariadna Padró-Miquel; Francesc Escrihuela-Vidal; Monica Carratini-Moraes; Emili Corbella; Xavier Corbella; Xavier Pintó
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

9.  Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.

Authors:  Antonio Fernández-Nebro; Íñigo Rúa-Figueroa; Francisco J López-Longo; María Galindo-Izquierdo; Jaime Calvo-Alén; Alejandro Olivé-Marqués; Carmen Ordóñez-Cañizares; María A Martín-Martínez; Ricardo Blanco; Rafael Melero-González; Jesús Ibáñez-Rúan; José Antonio Bernal-Vidal; Eva Tomero-Muriel; Esther Uriarte-Isacelaya; Loreto Horcada-Rubio; Mercedes Freire-González; Javier Narváez; Alina L Boteanu; Gregorio Santos-Soler; José L Andreu; José M Pego-Reigosa
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

10.  Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Julián Caro-Moreno; Nicolás Molano-González; Rubén D Mantilla; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2013-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.